Davison Jack sold $184K of GENI
Davison Jack (Chief Commercial Officer) sold 30,000 shares of Genius Sports Ltd (GENI) at $6.14 ($0.18M total) on 2026-11-12.
Genius Sports Ltd
Genius Sports is a business-to-business provider of technology, data and services for sports leagues and federations, sportsbooks, broadcasters, media companies, advertisers and brands. Headquartered in London, it supplies live sports data, video and tracking technology, betting content and services, performance analysis tools, officiating solutions, broadcast enhancements and fan engagement products. Its GeniusIQ platform uses computer vision, machine learning and AI to capture and interpret live sports action. Products include BetVision, an interactive watch-and-bet experience, and advertising and audience tools. Genius earns money by licensing and monetizing sports data and video rights, providing technology and services to customers, and offering advertising solutions. Sportsbook services range from live data feeds and oddsmaking to risk management and back-end operations, with customer arrangements that can include minimum payments and revenue sharing. Advertising is sold through managed campaigns and self-serve packages. The business also provides technology and infrastructure to sports partners, often in exchange for data rights.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No enriched coverage for $GENI in the last 7 days.
Davison Jack (Chief Commercial Officer) sold 30,000 shares of Genius Sports Ltd (GENI) at $6.14 ($0.18M total) on 2026-11-12.
JPMorgan maintained an Overweight rating and $8.00 price target on Genius Sports (NYSE:GENI) after its Q3 results. The company reported EBITDA of $87M, 2% above estimates, and raised its fiscal 2026 EBITDA guidance by 1%. Revenue grew 48% over the last year. Goldman Sachs lowered its price target to $9.00 but kept a Buy rating, citing strong revenue growth in the Betting segment.
Oppenheimer kept its Outperform rating on Genius Sports but reduced its price target to $10 from $12, citing a 16.7% decrease. This implies a 68.9% upside from the Nov 5 close of $5.92. Recent analyst price targets for Genius Sports range from $7 to $13.
Recent GENI coverage spans financial news, earnings and insider activity.
In the last 30 days, GENI insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($184K). The most active reporter was Davison Jack, Chief Commercial Officer, with 1 filing.
The insider sale may create modest selling pressure on GENI.
Analyst upgrade may support modest upside as the market prices in the new target.
Analyst downgrade reduces upside expectations.
Analyst target cut suggests weaker outlook.
Guidance raise and revenue beat suggest upside pressure.
AlphAI scores every news story that mentions GENI with an AI model for sentiment and relevance, and aggregates insider trades from Genius Sports Ltd's SEC EDGAR Form 4 filings. Figures refresh continuously.
Davison Jack (Chief Commercial Officer) sold 30,000 shares of Genius Sports Ltd (GENI) at $6.14 ($0.18M total) on 2026-11-12.
JPMorgan maintained an Overweight rating and $8.00 price target on Genius Sports (NYSE:GENI) after its Q3 results. The company reported EBITDA of $87M, 2% above estimates, and raised its fiscal 2026 EBITDA guidance by 1%. Revenue grew 48% over the last year. Goldman Sachs lowered its price target to $9.00 but kept a Buy rating, citing strong revenue growth in the Betting segment.
Oppenheimer kept its Outperform rating on Genius Sports but reduced its price target to $10 from $12, citing a 16.7% decrease. This implies a 68.9% upside from the Nov 5 close of $5.92. Recent analyst price targets for Genius Sports range from $7 to $13.
BTIG kept its Buy rating on Genius Sports but reduced its price target from $10 to $8, a 20% cut. This new target suggests a 35.1% upside from the Nov 5 closing price of $5.92, according to the firm.
Genius Sports (GENI) reported Q3 GAAP EPS of -$0.06, missing estimates by $0.06, but revenue of $270M (+62.4% Y/Y) beat by $8.79M. The company raised FY2026 revenue guidance to $1.015B-$1.035B and adjusted EBITDA guidance to $287M-$297M. Adjusted EBITDA rose 156.4% Y/Y to $87.1M, with a margin expansion of 1,190 basis points to 32.3%.
Genius Sports Ltd (GENI) furnished an SEC Form 6-K — earnings release. Exhibit 99.2 Genius Sports Beats Third Quarter Guidance; Raises Full-Year Outlook Delivered $54 Million of Free Cash Flow, 61% Free Cash Flow Conversion, and 32% Group Adjusted EBITDA Margin • Group Revenue of $270m, up 62% year-over-year, vs. guidance of $260m • Income from oper
Genius Sports (NYSE:GENI) expanded its partnership with the Argentine Football Association to introduce semi-automated offside technology in Argentina's top-flight football league. The system, which reduces offside decision times by over 30%, will launch in December 2026 and be fully deployed by July 2027. The technology uses AI and camera tracking to assist referees and provide real-time visualizations.
ARK Invest sold shares of Meta (META), AMD (AMD), Alphabet (GOOGL), and SpaceX (SPCX), while buying $6.7M in Kratos Defense (KTOS). Meta's sale was worth $14.3M, AMD's $14M, Alphabet's $8.7M, and SpaceX's $4.7M. Kratos, down 45% YTD, reported Q2 revenue of $458.8M, beating estimates.
ARK ETFs bought CoreWeave (CRWV) and Kratos (KTOS) for $19.68M and $9.15M, respectively, and sold Robinhood (HOOD) and Personalis (PSNL) for $17.01M and $12.01M. Other trades included Teradyne (TER), Recursion (RXRX), and smaller positions in several other companies.
Analysts cover five stocks: Genius Sports (GENI) with a $8 target, CF Industries (CF) with a $162 target, 3M (MMM) upgraded to Hold with a $171 target, Nike (NKE) downgraded to Sell with a $30 target, and Synopsys (SNPS) upgraded to Buy with a $700 target. Analysts cite growth, valuation, and market conditions as key factors.